Tackling Mycoplasma Contamination in Biotherapeutic Production

Mycoplasma contamination can silently compromise biotherapeutic production, making fast and reliable detection critical. This article explores how genomic DNA–based qPCR enables rapid, sensitive, and reproducible mycoplasma detection to support safer, more efficient biomanufacturing workflows.

Learn how DNA-based testing helps accelerate contamination investigations, improve lot-release confidence, and streamline GMP-compliant quality control with the Applied Biosystems^™ MycoSEQ^™ Plus system.

Download this article to learn:

• Same-day mycoplasma detection with DNA-based qPCR workflows
• Reliable, reproducible results powered by stable genomic DNA analysis
• Faster contamination tracing using quantitative Ct value insights
• Regulatory-aligned testing comparable to USP <63> methods
• Streamlined QC workflows with integrated automation and compliant software